|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.25 / 3.59|
Noble Capital Markets, a leading small-cap focused investment firm, announces the initiation of research coverage of ESSA Pharma.
Struggling Mass. biotech firm Epix Pharmaceuticals explores strategic options, including sale
Epix Pharmaceuticals may file for bankruptcy protection; offers cash and stock for debt
It may be best to wait for data from two clinical studies on Alzheimer's drug PRX-03140 before making any predictions about its prospects.
A wild day leaves major averages slightly higher. James Bianco opines on the credit crunch, and Dan Fitzpatrick on the search for Santa.
Adobe rises on earnings; iRobot shares salute Army contract.
Epix Pharmaceuticals sinks 15.6% on disappointing study results of its experimental anxiety drug.
Alexion and Epix Pharmaceuticals fall after setbacks in the drug approval process.